The strong underlying momentum across our business through the first nine months of the year sets us up well to sustain growth through 2026 and has us on track to deliver our 2030 ambition.
Pascal Soriot, Executive Director and Chief Executive Officer, AstraZeneca
We have
198
projects in our pipeline
